Core Insights - The latest episode of The Bell2Bell Podcast features Moishe Gubin, Chairman and CEO of Strawberry Fields REIT Inc., focusing on the company's operations in the skilled nursing and healthcare property sectors [2][3]. Company Overview - Strawberry Fields REIT is a self-administered real estate investment trust that owns, acquires, and leases skilled nursing and healthcare-related properties, with a portfolio of 142 facilities and over 15,500 beds across 10 states [7]. Business Model - The company operates on a triple-net lease structure with 10-year leases and two five-year renewal options, with 93% of its assets being skilled nursing facilities [3][4]. - The leadership team has a strong operational background in nursing homes, allowing for strategic tenant evaluations and operational stability [4]. Financial Performance - Strawberry Fields REIT has maintained a consistent financial discipline, having collected 100% of its rents over the past 10 years without writing off any bad loans [5]. - The company distributes 45% to 50% of its earnings, reinvesting the remainder to grow asset value at an annual rate of 11% [5].

Core Insights - Strawberry Fields REIT Inc. has appointed IBN to lead its corporate communications efforts, aiming to enhance its visibility in the market [1][4][5] Company Overview - Strawberry Fields REIT was spun out in 2015 with an initial portfolio of 33 properties in Indiana and Illinois, and has since expanded to own and lease healthcare facilities across 10 states [2] - The REIT currently owns and holds long-term leasehold interests in 142 healthcare facilities, totaling over 15,500 licensed beds, which include 130 skilled nursing facilities, 10 assisted living facilities, and 2 long-term acute care hospitals [3][6] Strategic Focus - The company's strategy emphasizes collaboration with regional operators and consultants, targeting markets with favorable demographic trends and regulatory conditions that support long-term demand for healthcare services [2] Communication Strategy - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and various media channels, to increase awareness of Strawberry Fields REIT among investors and the public [4][5]

Core Insights - Oncotelic Therapeutics Inc. has selected IBN to lead its corporate communications efforts, aiming to enhance awareness and engagement with investors and the public [1][5][6] Company Overview - Oncotelic is a clinical-stage biopharmaceutical company focused on developing RNA-based immunotherapy and targeted therapeutics for cancer and underserved diseases, particularly in difficult-to-treat and rare conditions [2][7] - The company’s lead candidate, OT-101, is currently in a Phase 3 trial for pancreatic ductal adenocarcinoma and has been evaluated for gliomas and metastatic tumors in combination with IL-2 and checkpoint inhibitors [2] Leadership and Innovation - Dr. Vuong Trieu, the Chairman and CEO, has a strong background in the industry, having filed over 500 patent applications with 75 issued to date, and co-invented Abraxane®, which was sold for $2.9 billion [3][8] - Oncotelic holds a 45% stake in GMP Biotechnology Limited, enabling support for regulatory filings for up to 20 drug candidates, and utilizes its proprietary AI platform, PDAOAI, for regulatory workflows and scientific data analysis [4][8] Strategic Partnerships - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and a large social media following, to promote Oncotelic Therapeutics [5][6] - The partnership aims to enhance Oncotelic's visibility among investors, journalists, and the general public, leveraging IBN's experience with over 500 client partners [6][9]

Core Insights - The BioMedWire Podcast features an interview with Panna Sharma, CEO of Lantern Pharma, focusing on the company's AI-driven approach to developing targeted cancer therapies [2][4] - Lantern Pharma's RADR® AI platform aims to address the high costs and long timelines associated with cancer drug development, which currently averages $250 billion annually and takes 10 to 12 years with a 93% failure rate [4][7] - The company is currently conducting three clinical trials for potential drug candidates, which could each be valued at several billion USD [2][4] Company Overview - Lantern Pharma is positioned as an AI-first company dedicated to creating innovative cancer medicines, leveraging machine learning and big data to enhance drug discovery [4][7] - The company has a pipeline of clinical-stage drug candidates targeting novel cancer mechanisms, with a focus on precision oncology, particularly in brain cancers [5][7] - Recent developments include the addition of a new board member from a recently acquired brain cancer company, indicating a strategic move to strengthen its expertise in this area [5] Market Outlook - Sharma anticipates significant advancements in treating difficult cancers, especially brain cancers, over the next five to seven years, marking a new era in precision neuro-oncology [5] - The recent approval of three brain cancer drugs after a long drought of 17 years highlights a shift in the market and potential opportunities for innovation in cancer treatment [5]

Core Insights - The BioMedWire Podcast features an interview with Robert Thast, CEO of Izotropic Corp, focusing on the company's innovative technologies for breast cancer screening and diagnosis [2][3][4] Company Overview - Izotropic Corp is a medical device company that is commercializing the IzoView Breast CT Imaging System, which aims to improve early cancer detection by identifying cancers as small as 2 millimeters, compared to the current standard of care that averages 11 millimeters [3][4] Technology and Innovation - The company has developed unique AI capabilities that are expected to gain acceptance in the market, potentially making Izotropic a target for acquisition by larger firms [5] - Izotropic's intellectual property strategy includes a portfolio of patents and trade secrets to protect its innovations in the imaging space [5] Market Strategy - The commercialization strategy involves a phased rollout of the IzoView system, starting in Europe and then expanding to the U.S., targeting hospitals, medical facilities, and imaging clinics [6] - The combined U.S. and European markets represent nearly 50% of the global market for breast imaging devices [6] Future Outlook - Securing FDA approval is seen as a critical milestone that would open up significant market opportunities for Izotropic [6]

Core Insights - GlobalTech Corp. has appointed IBN to lead its corporate communications efforts, aiming to enhance its visibility in the market [1][4] - The company focuses on balancing internal innovation with strategic acquisitions to drive growth and long-term value creation [2] - GlobalTech's portfolio includes AI-powered solutions across various sectors, with flagship platforms such as ThrivoAI and Baseball Blitz [2] Company Strategy - GlobalTech is actively pursuing technology-centric acquisitions and forming strategic regional alliances to strengthen its market presence [3] - The partnership with regional players like Omantel is crucial for growth in the Middle East, which is identified as a key market [3] Communication and Outreach - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and a large social media following, to promote GlobalTech [4][5] - IBN's experience with over 500 client partners and a diverse audience positions it well to enhance GlobalTech's outreach to investors and the public [5] Corporate Overview - GlobalTech is committed to growth in AI, big data, and frontier technologies, empowering innovative companies through strategic partnerships and investments [5] - The company aims to drive transformation across global markets by leveraging its diversified portfolio and expertise [5]

Company Overview - SEGG Media Corp. (NASDAQ: SEGG) is a technology company focused on the intersection of sports, entertainment, and gaming, operating under a portfolio that includes Sports.com, Concerts.com, and Lottery.com [2][8] - The company is committed to redefining digital fan engagement and ethical gaming through AI-driven live experiences [8] Leadership Insights - Matthew McGahan, President and CEO of SEGG Media, discussed the company's transformation since his involvement in October 2022, emphasizing a turnaround strategy that has repositioned Lottery.com within a broader tech-driven gaming framework [3][4] - McGahan highlighted an aggressive buy-and-build strategy aimed at expanding the value of SEGG Media's core brands, with a focus on identifying businesses that align with their verticals [5] Future Strategy - The company is poised for significant growth, with McGahan expressing confidence in the execution of their long-term vision and the importance of the next six months for upcoming acquisitions and announcements [6][5] - SEGG Media aims to transition from recovery to high-impact execution, indicating a shift in focus towards operational effectiveness and market expansion [6][5]

Core Insights - The latest episode of The MiningNewsWire Podcast features Pat Ryan, Chairman and CEO of Ucore Rare Metals Inc., discussing the company's role in developing rare earth element refining infrastructure in North America [2][5] - Ucore has received significant validation from the U.S. Department of Defense (DoD), including an $18.4 million investment and a $4 million contract for a commercial demonstration plant [4][5] - Ucore aims to disrupt China's control over the North American rare earth supply chain through strategic partnerships and the development of processing facilities in Louisiana, Canada, and Alaska [8] Company Overview - Ucore Rare Metals Inc. focuses on rare and critical metal resources, extraction, beneficiation, and separation technologies, with a vision to become a leading advanced technology company in the mining sector [7] - The company is transitioning from early-stage discussions to integrated commercial partnerships, emphasizing the importance of collaboration with the DoD [5] Industry Context - The podcast highlights the critical need for a robust supply chain for electric vehicles, which Ucore aims to address through innovative manufacturing and refining processes [3] - Ucore's initiatives are part of a broader effort to enhance the Western critical minerals supply chain, responding to increasing demand for rare earth elements [8]

Core Insights - AI Maverick Intel Inc. has appointed IBN to lead its corporate communications efforts, aiming to enhance its visibility in the market [1][5] - The company focuses on transforming customer acquisition and engagement through its AI-powered platform, which has applications across various sectors including healthcare, biotech, insurance, and transportation [2][4] - AI Maverick's recent platform launch in July 2025 features advanced capabilities for managing sales engagements, significantly reducing deal cycles and acquisition costs [3][4] Company Overview - AI Maverick Intel is positioned as an AI-first operator following its rebranding and acquisition of the AI Maverick platform in May 2025, emphasizing scalable automation and strategic business combinations [2][4] - The company aims to redefine business relationships and drive growth through intelligent engagement, targeting the expanding AI-in-marketing sector projected to reach $82.23 billion by 2030 [4] Communication Strategy - IBN will utilize its extensive distribution network, which includes over 5,000 syndication outlets and various media channels, to increase awareness for AI Maverick Intel [5][6] - IBN has a strong track record with over 19 years of experience and a large audience base, which will support AI Maverick in reaching investors and the general public effectively [6][7]

Core Insights - LaFleur Minerals Inc. is positioned as a near-term gold producer with advanced projects in Québec's Abitibi Gold Belt, leveraging a permitted mill and strategic acquisitions [2][3][4] Company Overview - LaFleur Minerals focuses on gold exploration and development, particularly in the Abitibi region of Québec, with significant assets including the Swanson Gold Project and the Beacon Gold Mill [7][8] - The Swanson Gold Project spans approximately 16,600 hectares and includes multiple gold-rich prospects, enhancing its development potential [8] Strategic Positioning - The company acquired the Beacon Gold Mill, which has been upgraded with a $20 million investment, allowing for processing capabilities of over 750 tonnes per day [4][9] - LaFleur's strategy includes not only producing from its own properties but also potentially processing material from other nearby gold projects, capitalizing on the current high gold prices exceeding $3,000 per ounce [5][4] Leadership Insights - CEO Paul Ténière emphasized the company's accelerated timeline for production and the economic viability of its projects due to rising gold prices [5][4] - Chairman Kal Malhi discussed the strategic acquisition of assets from a bankruptcy situation, positioning LaFleur for rapid development in the gold sector [3][4]